J.A. García‐Sevilla

1.0k total citations
19 papers, 936 citations indexed

About

J.A. García‐Sevilla is a scholar working on Molecular Biology, Cellular and Molecular Neuroscience and Organic Chemistry. According to data from OpenAlex, J.A. García‐Sevilla has authored 19 papers receiving a total of 936 indexed citations (citations by other indexed papers that have themselves been cited), including 14 papers in Molecular Biology, 13 papers in Cellular and Molecular Neuroscience and 3 papers in Organic Chemistry. Recurrent topics in J.A. García‐Sevilla's work include Neuroscience and Neuropharmacology Research (8 papers), Receptor Mechanisms and Signaling (8 papers) and Neurotransmitter Receptor Influence on Behavior (8 papers). J.A. García‐Sevilla is often cited by papers focused on Neuroscience and Neuropharmacology Research (8 papers), Receptor Mechanisms and Signaling (8 papers) and Neurotransmitter Receptor Influence on Behavior (8 papers). J.A. García‐Sevilla collaborates with scholars based in Spain, Switzerland and Sweden. J.A. García‐Sevilla's co-authors include M Assumpció Boronat, Gabriel Olmos, Fernando Barturen, Antonio Miralles, M. Julia García‐Fuster, Magdalena Sastre, Iñaki Martín, Liisa Ahtee, Arvid Carlsson and Tor Magnusson and has published in prestigious journals such as Biological Psychiatry, Annals of the New York Academy of Sciences and Journal of Neurochemistry.

In The Last Decade

J.A. García‐Sevilla

19 papers receiving 915 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
J.A. García‐Sevilla Spain 13 701 555 178 92 62 19 936
M.B. Hesselink Netherlands 18 665 0.9× 403 0.7× 135 0.8× 118 1.3× 41 0.7× 30 955
Dao‐Yao He United States 15 866 1.2× 508 0.9× 148 0.8× 73 0.8× 39 0.6× 18 1.2k
C M Fattaccini France 14 866 1.2× 527 0.9× 198 1.1× 130 1.4× 127 2.0× 15 1.1k
Karla Drescher Germany 17 607 0.9× 488 0.9× 77 0.4× 166 1.8× 51 0.8× 31 1.0k
S. Sagratella Italy 18 799 1.1× 388 0.7× 144 0.8× 64 0.7× 67 1.1× 77 1.0k
Virginia A. Boundy United States 15 842 1.2× 609 1.1× 135 0.8× 111 1.2× 54 0.9× 15 1.1k
Tiejun Xu China 12 522 0.7× 410 0.7× 110 0.6× 71 0.8× 56 0.9× 14 992
Sami Ben Hamida United States 23 932 1.3× 582 1.0× 127 0.7× 166 1.8× 51 0.8× 43 1.3k
M Assumpció Boronat Spain 9 404 0.6× 307 0.6× 144 0.8× 57 0.6× 36 0.6× 10 572
Naheed Mirza Denmark 19 486 0.7× 508 0.9× 185 1.0× 80 0.9× 34 0.5× 24 857

Countries citing papers authored by J.A. García‐Sevilla

Since Specialization
Citations

This map shows the geographic impact of J.A. García‐Sevilla's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by J.A. García‐Sevilla with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites J.A. García‐Sevilla more than expected).

Fields of papers citing papers by J.A. García‐Sevilla

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by J.A. García‐Sevilla. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by J.A. García‐Sevilla. The network helps show where J.A. García‐Sevilla may publish in the future.

Co-authorship network of co-authors of J.A. García‐Sevilla

This figure shows the co-authorship network connecting the top 25 collaborators of J.A. García‐Sevilla. A scholar is included among the top collaborators of J.A. García‐Sevilla based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with J.A. García‐Sevilla. J.A. García‐Sevilla is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

19 of 19 papers shown
1.
Ramos‐Miguel, Alfredo, J. Javier Meana, & J.A. García‐Sevilla. (2011). P.3.d.003 The cdk5 cofactor p35 is reduced in schizophrenia postmortem brains: downregulation of cdk5/p35/p25 after antipsychotic medication. European Neuropsychopharmacology. 21. S507–S508. 1 indexed citations
2.
García‐Sevilla, J.A., et al.. (2003). In Vivo Effects of the I2‐Alkylating Agent BU99006 on the Immunodensity of Imidazoline Receptor Proteins in the Mouse Brain. Annals of the New York Academy of Sciences. 1009(1). 323–331. 5 indexed citations
3.
García‐Sevilla, J.A., et al.. (2003). Neurofilament proteins and cAMP pathway in brains of μ-, δ- or κ-opioid receptor gene knock-out mice: effects of chronic morphine administration. Neuropharmacology. 46(4). 519–530. 27 indexed citations
4.
Ribas, Catalina, Antonio Miralles, Xavier Busquets, & J.A. García‐Sevilla. (2001). Brain α2‐adrenoceptors in monoamine‐depleted rats: increased receptor density, G coupling proteins, receptor turnover and receptor mRNA. British Journal of Pharmacology. 132(7). 1467–1476. 24 indexed citations
5.
Boronat, M Assumpció, M. Julia García‐Fuster, & J.A. García‐Sevilla. (2001). Chronic morphine induces up‐regulation of the pro‐apoptotic Fas receptor and down‐regulation of the anti‐apoptotic Bcl‐2 oncoprotein in rat brain. British Journal of Pharmacology. 134(6). 1263–1270. 118 indexed citations
6.
Casanovas, Anna, Gabriel Olmos, Joan Ribera, et al.. (2000). Induction of reactive astrocytosis and prevention of motoneuron cell death by the I2‐imidazoline receptor ligand LSL 60101. British Journal of Pharmacology. 130(8). 1767–1776. 25 indexed citations
7.
Sánchez‐Blázquez, Pilar, M Assumpció Boronat, Gabriel Olmos, J.A. García‐Sevilla, & Javier Garzón. (2000). Activation of I2‐imidazoline receptors enhances supraspinal morphine analgesia in mice: a model to detect agonist and antagonist activities at these receptors. British Journal of Pharmacology. 130(1). 146–152. 81 indexed citations
8.
Esteban, Susana, et al.. (1999). Activation and desensitization by cyclic antidepressant drugs of α2-autoreceptors, α2-heteroreceptors and 5-HT1A-autoreceptors regulating monoamine synthesis in the rat brain in vivo. Naunyn-Schmiedeberg s Archives of Pharmacology. 360(2). 135–143. 61 indexed citations
9.
Olmos, Gabriel, Núria DeGregorio‐Rocasolano, Maria Paz Regalado, et al.. (1999). Protection by imidazol(ine) drugs and agmatine of glutamate‐induced neurotoxicity in cultured cerebellar granule cells through blockade of NMDA receptor. British Journal of Pharmacology. 127(6). 1317–1326. 153 indexed citations
10.
Ozaita, Andrés, Gabriel Olmos, M Assumpció Boronat, et al.. (1997). Inhibition of monoamine oxidase A and B activities by imidazol(ine)/guanidine drugs, nature of the interaction and distinction from I2‐imidazoline receptors in rat liver. British Journal of Pharmacology. 121(5). 901–912. 76 indexed citations
11.
García‐Sevilla, J.A., et al.. (1997). Immunoreactive α2a-adrenoceptors and associated regulatory proteins in brains of suicides. Biological Psychiatry. 42(1). 285S–286S. 1 indexed citations
12.
Escribá, Pablo V., Andrés Ozaita, Antonio Miralles, Donald J. Reis, & J.A. García‐Sevilla. (1995). Pharmacological and Immunological Characterization of Solubilized 130–140‐ and 66‐kD Imidazoline Receptors in the Rat Brainfn1. Annals of the New York Academy of Sciences. 763(1). 169–171. 1 indexed citations
13.
García‐Sevilla, J.A., et al.. (1995). Effects of the I2‐Imidazoline Receptor Ligand LSL 60101 on Various Models of Anorexia in Ratsfn1. Annals of the New York Academy of Sciences. 763(1). 494–496. 4 indexed citations
14.
Miralles, Antonio, Gabriel Olmos, Magdalena Sastre, et al.. (1993). Discrimination and pharmacological characterization of I2-imidazoline sites with [3H]idazoxan and alpha-2 adrenoceptors with [3H]RX821002 (2-methoxy idazoxan) in the human and rat brains.. Journal of Pharmacology and Experimental Therapeutics. 264(3). 1187–1197. 134 indexed citations
15.
Barturen, Fernando & J.A. García‐Sevilla. (1992). Long term treatment with desipramine increases the turnover of alpha 2-adrenoceptors in the rat brain.. Molecular Pharmacology. 42(5). 846–855. 54 indexed citations
16.
Olmos, Gabriel, Antonio Miralles, Fernando Barturen, & J.A. García‐Sevilla. (1992). Characterization of brain imidazoline receptors in normotensive and hypertensive rats: differential regulation by chronic imidazoline drug treatment.. Journal of Pharmacology and Experimental Therapeutics. 260(3). 1000–1007. 44 indexed citations
17.
Olmos, Gabriel, Antonio Miralles, Fernando Barturen, & J.A. García‐Sevilla. (1991). Repeated Idazoxan Increases Brain Imidazoline Receptors in Normotensive (WKY) but Not in Hypertensive (SHR) Rats. Journal of Neurochemistry. 57(5). 1811–1813. 6 indexed citations
18.
García‐Sevilla, J.A. & J. Zubieta. (1986). Activation and desensitization of presynaptic α2‐adrenoceptors after inhibition of neuronal uptake by antidepressant drugs in the rat vas deferens. British Journal of Pharmacology. 89(4). 673–683. 37 indexed citations
19.
García‐Sevilla, J.A., Liisa Ahtee, Tor Magnusson, & Arvid Carlsson. (1978). Opiate-receptor mediated changes in monoamine synthesis in rat brain. Journal of Pharmacy and Pharmacology. 30(1). 613–621. 84 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026